FDA Drug Application (206323) for CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE by SPRIASO LLC

Back to FDA Applications sponsored by SPRIASO LLC

Application Number206323
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage8MG;54.3MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
Active IngredientCHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient CHLORPHENIRAMINE MALEATE23
List of drugs with Active Ingredient CODEINE PHOSPHATE51


Back to FDA Applications sponsored by SPRIASO LLC